about
Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactomeComparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinityMechanisms of resistance in castration-resistant prostate cancer (CRPC)Current opinion on the role of testosterone in the development of prostate cancer: a dynamic modelTargeting molecular resistance in castration-resistant prostate cancerHigh-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancerCell proliferation and expression of cell cycle regulatory proteins that control the G1/S transition are age dependent and lobe specific in the Brown Norway rat model of prostatic hyperplasiaSocial environment during egg laying: Changes in plasma hormones with no consequences for yolk hormones or fecundity in female Japanese quail, Coturnix japonica.C/EBPalpha redirects androgen receptor signaling through a unique bimodal interactionMaternal cypermethrin exposure during the perinatal period impairs testicular development in C57BL male offspring.Kinase modulation of androgen receptor signaling: implications for prostate cancerModulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.Is there any clinical relevant difference between non mosaic Klinefelter Syndrome patients with or without Androgen Receptor variations?Perinatal exposure to low-dose methoxychlor impairs testicular development in C57BL/6 miceTranscriptional regulation of cell adhesion at the blood-testis barrier and spermatogenesis in the testis.Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT.Testosterone exacerbates neuronal damage following cardiac arrest and cardiopulmonary resuscitation in mouse.Differential sensitivity of Pak5, Pak6, and Pak5/Pak6 double-knockout mice to the stimulant effects of amphetamine and exercise-induced alterations in body weight.The androgen receptor gene and its influence on the development and progression of prostate cancer.Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer.Androgen receptor signaling and mutations in prostate cancerDifferential effects of testosterone, dihydrotestosterone and estradiol on carotenoid deposition in an avian sexually selected signal.Andropause: clinical implications of the decline in serum testosterone levels with aging in men.A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements.Non-genomic actions of androgens.The androgen receptor: structure, mutations, and antiandrogens.Androgen Receptors Expression in Pituitary of Male Viscacha in relation to Growth and Reproductive Cycle.Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.Pharmacogenetics of human androgens and prostate cancer--an update.Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograftRedox regulation of human estrogen sulfotransferase (hSULT1E1)Insufficient androgen and FSH signaling may be responsible for the azoospermia of the infantile primate testes despite exposure to an adult-like hormonal milieuTRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells.A single pill to treat postmenopausal hypertension? Not yetAn androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells.Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)Emerging therapeutic targets in metastatic progression: A focus on breast cancer.Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor.
P2860
Q24294625-C6EFB55D-0523-4C6B-9A66-54F654F77966Q24647922-708F79A3-EFA1-4644-9A22-5644DB17BE77Q26774221-983F15E5-8D56-41E6-B817-2DE4E147D3DAQ26778886-B67BAEDC-8506-4E68-9320-BB871A054BA4Q26795445-AB401C9C-09EB-4541-BF82-08559D8269ACQ28480861-20213158-BBF8-49AA-BE23-586347866805Q28572109-07284D6E-2151-4A9E-91A6-5A4DEAC7CFBCQ30356536-3E764ED4-1FF2-4492-9974-108F089D7BA4Q30446961-D85BABDB-E981-4D3A-AE82-3C5BD76BE0FAQ33584132-1A897FF0-92B8-4AAA-969F-4CF649FF1755Q33757289-9141AE29-2B68-4C5A-AF92-B49C5795FF65Q33775726-BA60F3F1-50F3-4A6A-896F-AC03F91CC027Q33793955-EE3BD39E-B1E6-4048-8C2F-03FAA7E755AAQ33928232-D3D4B494-2E4F-453A-BD07-1D2A69204D74Q33939295-CAEC733B-4DAE-44AC-88D7-9303E44EDD76Q33962627-A79A420F-CBDC-443D-A503-40019DA9B5ABQ34159170-EC58E13E-6762-4C2A-B670-24F0A0DA9A0EQ34346996-E9571C83-0A36-4480-B825-94B3AB85A66EQ34395691-24E6294A-9048-49BC-AFED-36A6E4F6FC42Q34419367-896E143D-7A52-4074-A6F7-16C50688EF96Q34425907-CD0A46AF-1BE5-40FB-A46D-79B1B7ABA625Q34467689-DD61BB54-5CE2-4CDB-A02B-238D067E783EQ34511442-FEF19C39-5ABF-42B5-A2D6-550D9E7CF7CBQ34550256-1A6E8E38-8C8C-49E3-95E0-06301886B561Q34712118-D963A2AA-FD47-40E5-9C8A-F07E7545A969Q34727863-7416FAC5-CC0F-4156-BE49-A092E203BBC9Q35193278-74C2C9FB-60F4-452F-A97B-9E074EE2593BQ35508701-505768CD-27F8-4ED7-A642-AFFE3F358F26Q35665662-730045FC-87E4-4327-99E2-2E59FB933C1CQ35753329-9AB3DBA8-49AC-4D4C-8429-F94527BB30C5Q35788627-1FE8DA69-4622-464F-AA55-F2F14E8976C4Q35945125-5FDF278A-058D-42BB-AE76-E0372C3360CDQ36100148-940AD72A-7757-4805-A2D7-14AFECF92EDCQ36232009-827E705A-8602-4885-89A8-A91C7CAA9BA2Q36291970-9AAF9D1B-537E-427F-A266-F80163B598A8Q36389442-CB514484-A24F-47F9-8453-52BFCB97E35DQ36527148-01908277-14AA-4A4F-9EE4-607BD7D4A2DDQ36759766-CFF28BDD-20DA-4BAD-89C2-AF6976CF2633Q36854062-4E8CACAD-01D6-40D1-82F0-CB0C41F12480Q37084688-6BDB68EC-585F-4C02-A69B-555D411A8BFA
P2860
description
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Jahr 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/01/01)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/01/01)
@nl
наукова стаття, опублікована в січні 1999
@uk
مقالة علمية (نشرت عام 1999)
@ar
name
Regulation of androgen action
@ast
Regulation of androgen action
@en
Regulation of androgen action
@nl
type
label
Regulation of androgen action
@ast
Regulation of androgen action
@en
Regulation of androgen action
@nl
prefLabel
Regulation of androgen action
@ast
Regulation of androgen action
@en
Regulation of androgen action
@nl
P2093
P3181
P1476
Regulation of androgen action
@en
P2093
B. Chatterjee
C. S. Song
M. H. Jung
N. K. Velu
Y. Lavrovsky
P304
P3181
P356
10.1016/S0083-6729(08)60938-3
P577
1999-01-01T00:00:00Z